Arcus Biosciences

$20.42
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.31 (-1.50%) As of 11:12 AM EDT today

Why Robinhood?

You can buy or sell RCUS and other stocks, options, and ETFs commission-free!

About RCUS

Arcus Biosciences, Inc. engages in the development and commercialization of immunotherapies. The firm competes in the segments of the pharmaceutical, biotechnology and other related markets that develop immunotherapies for the treatment of cancer. Read More The company was founded by Terry J. Rosen and Juan Carlos Jaen in 2015 and is headquartered in Hayward, CA. The listed name for RCUS is Arcus Biosciences, Inc.

Employees
139
Headquarters
Hayward, California
Founded
2015
Market Cap
1.34B
Price-Earnings Ratio
Dividend Yield
Average Volume
535.23K
High Today
$20.64
Low Today
$19.55
Open Price
$20.26
Volume
131.11K
52 Week High
$37.41
52 Week Low
$7.19

Collections

RCUS Earnings

-$0.93
-$0.62
-$0.31
-$0.00
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Q2 2020
Q3 2020
Estimated
per share
Actual
Expected Nov 10, After Hours

You May Also Like